Corindus investors approve Siemens merger

Shareholders of vascular robotics developer Corindus Vascular Robotics have approved the $1.1 billion merger with Siemens Healthineers. Under the terms of the agreement, Corindus shareholders will receive $4.28 in cash per share they own. After the transaction closes, Corindus’ shares will therefore be delisted from the NYSE American. “Corindus has established a leading position in […]